Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinath Kasturirangan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biotechnology Progress|July 3, 2009
Promoting alpha-secretase cleavage of beta-amyloid with engineered proteolytic antibody fragmentsSrinath Kasturirangan, Dan Brune, Michael Sierks
Biochemistry|May 1, 2010
Engineered proteolytic nanobodies reduce Abeta burden and ameliorate Abeta-induced cytotoxicitySrinath Kasturirangan, Shanta Boddapati, Michael R Sierks
Journal of Alzheimer'S Disease : JAD|December 14, 2011
Bispecific tandem single chain antibody simultaneously inhibits β-secretase and promotes α-secretase processing of AβPPShanta Boddapati, Yona Levites, Vick Suryadi, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 15, 2011
CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative diseaseMichael R Sierks, Gaurav Chatterjee, Claire McGraw, et al.
The Journal of Biological Chemistry|January 15, 2009
Detecting morphologically distinct oligomeric forms of alpha-synucleinSharareh Emadi, Srinath Kasturirangan, Min S Wang, et al.
Journal of Molecular Biology|October 22, 2008
Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cellsAndleeb Zameer, Srinath Kasturirangan, Sharareh Emadi, et al.
Neurobiology of Aging|November 12, 2010
Nanobody specific for oligomeric β-amyloid stabilizes nontoxic formSrinath Kasturirangan, Lin Li, Sharareh Emadi, et al.
Journal of Pharmaceutical Sciences|July 10, 2019
Characterization of a Novel Bispecific Antibody With Improved Conformational and Chemical StabilityPrakash Manikwar, Sri Hari Raju Mulagapati, Srinath Kasturirangan, et al.
Biotechnology Progress|January 30, 2013
Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samplesSrinath Kasturirangan, Tim Reasoner, Philip Schulz, et al.
Mabs|March 6, 2024
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodiesKristina M J Aertker, Minu Ravindra Pilvankar, Tobias M Prass, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biotechnology Progress|July 3, 2009
Promoting alpha-secretase cleavage of beta-amyloid with engineered proteolytic antibody fragmentsSrinath Kasturirangan, Dan Brune, Michael Sierks
Biochemistry|May 1, 2010
Engineered proteolytic nanobodies reduce Abeta burden and ameliorate Abeta-induced cytotoxicitySrinath Kasturirangan, Shanta Boddapati, Michael R Sierks
Journal of Alzheimer'S Disease : JAD|December 14, 2011
Bispecific tandem single chain antibody simultaneously inhibits β-secretase and promotes α-secretase processing of AβPPShanta Boddapati, Yona Levites, Vick Suryadi, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|November 15, 2011
CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative diseaseMichael R Sierks, Gaurav Chatterjee, Claire McGraw, et al.
The Journal of Biological Chemistry|January 15, 2009
Detecting morphologically distinct oligomeric forms of alpha-synucleinSharareh Emadi, Srinath Kasturirangan, Min S Wang, et al.
Journal of Molecular Biology|October 22, 2008
Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cellsAndleeb Zameer, Srinath Kasturirangan, Sharareh Emadi, et al.
Neurobiology of Aging|November 12, 2010
Nanobody specific for oligomeric β-amyloid stabilizes nontoxic formSrinath Kasturirangan, Lin Li, Sharareh Emadi, et al.
Journal of Pharmaceutical Sciences|July 10, 2019
Characterization of a Novel Bispecific Antibody With Improved Conformational and Chemical StabilityPrakash Manikwar, Sri Hari Raju Mulagapati, Srinath Kasturirangan, et al.
Biotechnology Progress|January 30, 2013
Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samplesSrinath Kasturirangan, Tim Reasoner, Philip Schulz, et al.
Mabs|March 6, 2024
Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodiesKristina M J Aertker, Minu Ravindra Pilvankar, Tobias M Prass, et al.
Pageof 2